Status of nutrition and health claims in Europe

Verhagen, Hans; Vos, Ellen; Francl, Sheila; Heinonen, Marina; Loveren, Henk Van

doi:10.1016/j.abb.2010.04.012

Cited by 101 publications

(97 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Blood cholesterol lowering may reduce the risk of coronary heart disease' (29,30) . This advice has been provided to the European Commission and member states who will adopt and authorise the health claims (31) .…”

Section: Mechanism Of Supporting Statin Therapymentioning

confidence: 99%

Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

et al. 2010

Self Cite

View full text Add to dashboard Cite

Functional foods and dietary supplements might have a role in supporting drug therapy. These products may (1) have an additive effect to the effect that a drug has in reducing risk factors associated with certain conditions, (2) contribute to improve risk factors associated with the condition, other than the risk factor that the drug is dealing with, or (3) reduce drug-associated side effects, for example, by restoring depleted compounds or by reducing the necessary dose of the drug. Possible advantages compared with a multidrug therapy are lower drug costs, fewer side effects and increased adherence. In the present review we have focused on the support of statin therapy using functional foods or dietary supplements containing plant sterols and/or stanols, soluble dietary fibre, n-3 PUFA or coenzyme Q 10 . We conclude that there is substantial evidence that adding plant sterols and/or stanols to statin therapy further reduces total and LDL-cholesterol by roughly 6 and 10 %, respectively. Adding n-3 PUFA to statin therapy leads to a significant reduction in plasma TAG of at least 15 %. Data are insufficient and not conclusive to recommend the use of soluble fibre or coenzyme Q 10 in patients on statin therapy and more randomised controlled trials towards these combinations are warranted. Aside from the possible beneficial effects from functional foods or dietary supplements on drug therapy, it is important to examine possible (negative) effects from the combination in the long term, for example, in post-marketing surveillance studies. Moreover, it is important to monitor whether the functional foods and dietary supplements are taken in the recommended amounts to induce significant effects. Combination therapy: Dyslipidaemia: Statins: Functional foodsThe world market for functional foods (FF) and dietary supplements (DS) is expanding rapidly. In 2010 FF are expected to represent 5 % of the total global food market (1) and the market for DS is estimated at more than $60 billion worldwide (2) . In general, the target population of FF or DS is healthy individuals with slightly elevated risk factors or some physical discomfort. However, due to the fast growing market of FF or DS and the accompanying strong advertising and marketing, also patients on medication may be stimulated to use FF or DS. This may have several consequences for the quality of drug treatment as stated by de Jong et al. with the example of the combined intake of plant sterols and/or stanols and statins (3) . Whereas they addressed the additive effect of plant sterols and/or stanols on reducing LDL-cholesterol values in patients on statin treatment, their main focus was the possible negative aspects of the combination, such as unfavourable effects on patient adherence with drug treatment and increasing the potential for food-drug interactions.In the present review we will focus on the possible beneficial effects that FF or DS may have on drug therapy. Because of the large number of subjects treated suboptimally with statins (hydroxymethylglutaryl Co...

show abstract

Section: Mechanism Of Supporting Statin Therapymentioning

confidence: 99%

Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

et al. 2010

Self Cite

View full text Add to dashboard Cite

show abstract

“…Increasing use of health claims on foods over the past 20 years has led to the development of legislation to regulate their use in a number of global regions, including the EU (1)(2)(3) , USA (4,5) , Canada (6) , Japan (7,8) , China (9) and Australia/New Zealand (10) . Such legislation is needed in order to prevent the use of unsubstantiated health claims on foods, which can mislead consumers and result in unfair competition.…”

mentioning

confidence: 99%

Scientific substantiation of health claims in the EU

Flynn

2011

Proc. Nutr. Soc.

View full text Add to dashboard Cite

EU legislation on nutrition and health claims made on foods (Regulation (EC) No. 1924 specifies that health claims should be only authorised for use in the Community after a scientific assessment of the highest possible standard is carried out by the European Food Safety Authority (EFSA). This paper focuses on the scientific substantiation of health claims within the context of the EU Regulation. The evaluation of the substantiation of health claims is carried out by the EFSA Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA). The EFSA has published extensive guidance to assist applicants in the preparation of applications for authorisations of health claims. This guidance summarises the general principles applied by the NDA Panel in the evaluation of health claims, including the scientific criteria for substantiation, as well as the scientific requirements for the substantiation of specific health claims. To date, the EFSA NDA Panel has concluded that a wide range of health claims has been substantiated. These include claims for many well-established functions of nutrients, as well as beneficial effects of foods and food constituents on a range of body functions. In addition, claims have been substantiated on the role of nutrients in growth and development of children and on the effects of nutrients and food constituents on reduction of risk factors for disease. EFSA evaluations and guidance have made an important contribution to the understanding of the scientific substantiation of health claims which will help to set new directions for research and will guide future innovation.

show abstract

“…It was observed that for FF consumption to increase, consumer attitudes need to change. In concrete terms, clear information on the packaging or labelling (nutrition and health claims), better campaigns to inform consumers about the benefits of FFs in the diet (Leathwood, Richardson, Sträter, Tood, & Van Trijp, 2007;Verhagen et al, 2010) and a number of promotional activities should be considered to bring about cultural change and prevent FF product failure. In general, it was observed that the weight of the food choice factors on purchasing behaviour was very low, and further research would be required to investigate this relationship in greater depth.…”

Section: 3mentioning

confidence: 99%

“…However, this concept is not an official one, due to the lack of any specific legislation or recognized international definition (Krystallis, Maglaras, & Mamalis, 2008 (Verhagen, Vos, Francl, Heinonen, & Van Loveren, 2010), familiarity with the ingredients added , or gender, age, country and cultural values Siegrist, Stampfli, & Kastenholz, 2008). In addition, it is known that FF are not perceived as an homogeneous group because of being a diverse category of enriched food, however, the attitude to the global idea of this food market trend is still studied (Urala & Lähteenmäki, 2003).…”

Section: Introductionmentioning

confidence: 99%

“…Furthermore, other authors have pointed out that even though consumers know about health benefits, that does not mean that the food will be eaten (Aikman, Min & Graham, 2006 (Verhagen, Vos, Francl, Heinonen & Loveren, 2010), familiarity with the ingredients , gender, age, country differences and cultural values Siegrist, Stampfli & Kastenholz, 2008).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Estudio de las actitudes, conocimientos y comportamientos de los consumidores. Parámetros sensoriales y no sensoriales que intervienen en la elección de alimentos bajos en calorías y enriquecidos con ingredientes funcionales

Alava¹,

Elizabeth²

View full text Add to dashboard Cite

Status of nutrition and health claims in Europe

Cited by 101 publications

References 20 publications

Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

Scientific substantiation of health claims in the EU

Estudio de las actitudes, conocimientos y comportamientos de los consumidores. Parámetros sensoriales y no sensoriales que intervienen en la elección de alimentos bajos en calorías y enriquecidos con ingredientes funcionales

Contact Info

Product

Resources

About